Sabby Management, LLC Lixte Biotechnology Holdings, Inc. Transaction History

Sabby Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.12 - $0.35 $11,957 - $34,875	99,644 New	99,644 $74,000
Q3 2021 Nov 15, 2021	SELL	$0.52 - $0.85 $34,065 - $55,684	-65,511 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$0.46 - $0.89 $6,543 - $12,659	-14,224 Reduced 17.84%	65,511 $199,000
Q1 2021 May 17, 2021	BUY	$0.8 - $1.2 $63,788 - $95,682	79,735 New	79,735 $262,000

Ticker LIXT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,646,600
Market Cap $33M
Description
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.